This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| bacteria:t3e:xopq [2023/10/02 21:30] – [XopQ] rkoebnik | bacteria:t3e:xopq [2025/11/24 14:24] (current) – jfpothier | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== XopQ ====== | + | ====== |
| - | Author: Valérie Olivier | + | Author: Valérie Olivier, [[https:// |
| Internal reviewer: [[https:// | Internal reviewer: [[https:// | ||
| - | Expert reviewer: **WANTED!** | ||
| Class: XopQ\\ | Class: XopQ\\ | ||
| Line 10: | Line 9: | ||
| GenBank ID: [[https:// | GenBank ID: [[https:// | ||
| RefSeq ID: [[https:// | RefSeq ID: [[https:// | ||
| - | 3D structure: [[https:// | + | 3D structure: [[https:// |
| ===== Biological function ===== | ===== Biological function ===== | ||
| Line 17: | Line 16: | ||
| XopQ was identified in a genetic screen, using a Tn// | XopQ was identified in a genetic screen, using a Tn// | ||
| + | |||
| === (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
| Type III-dependent secretion was confirmed using a calmodulin-dependent adenylate cyclase reporter assay, with a Δ//hrpF// mutant strain serving as negative control (Roden //et al//., 2004). Using an AvrBs1 reporter fusion, XopQ< | Type III-dependent secretion was confirmed using a calmodulin-dependent adenylate cyclase reporter assay, with a Δ//hrpF// mutant strain serving as negative control (Roden //et al//., 2004). Using an AvrBs1 reporter fusion, XopQ< | ||
| + | |||
| === Regulation === | === Regulation === | ||
| The //xopQ// < | The //xopQ// < | ||
| - | qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//) were significantly reduced in the // | + | qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//) were significantly reduced in the // |
| === Phenotypes === | === Phenotypes === | ||
| - | * Roden //et al//. did not find significant growth defects of a // | + | * Roden //et al//. did not find significant growth defects of a //Xcv// Δ//xopQ// mutant in susceptible pepper and tomato leaves (Roden //et al//., 2004). |
| - | * XopQ< | + | * XopQ< |
| - | * In //X. oryzae// | + | * In //X. oryzae// pv. //oryzae// (//Xoo//), XopQ was described by Sinha //et al//. to suppress DAMP-induced PTI in rice. Indeed, //Xoo// secretes hydrolytic enzymes such as LipA (Lipase/ |
| - | * XopQ< | + | * XopQ< |
| - | * Consistent with a role in ETI, TFT4 mRNA abundance increased during the incompatible interaction of tomato and pepper with // | + | * Consistent with a role in ETI, TFT4 mRNA abundance increased during the incompatible interaction of tomato and pepper with //Xcv// (Teper //et al//., 2014). |
| - | * Mutations of two potential active site residues, D116 and Y279, resulted in // | + | * Mutations of two potential active site residues, D116 and Y279, resulted in //Xoo// mutants with reduced virulence on rice and reduced hypersensitive response (HR) on //Nicotiana benthamiana//, |
| - | * Compatibility studies with //X. euvesicatoria// | + | * Compatibility studies with //X. euvesicatoria// |
| - | * The avirulence activity of XopQ derivatives did not correlate with macroscopically visible plant reactions upon transient expression in //N. benthamiana// | + | * The avirulence activity of XopQ derivatives did not correlate with macroscopically visible plant reactions upon transient expression in //N. benthamiana// |
| - | * Transient co-expression of XopQ::GFP and XopS::GFP in //N. benthamiana// | + | * Transient co-expression of XopQ::GFP and XopS::GFP in //N. benthamiana// |
| - | * XopQ suppressed cell death reactions in //N. benthamiana// | + | * XopQ suppressed cell death reactions in //N. benthamiana// |
| - | * XopQ-mediated cell death suppression in //N. benthamiana// | + | * XopQ-mediated cell death suppression in //N. benthamiana// |
| - | * A Δ// | + | * A Δ// |
| - | * A reverse genetics screen identified Recognition of XopQ 1 (Roq1), a nucleotide-binding leucine-rich repeat (NLR) protein with a Toll-like interleukin-1 receptor (TIR) domain, which mediates XopQ recognition in //N. benthamiana// | + | * A reverse genetics screen identified Recognition of XopQ 1 (Roq1), a nucleotide-binding leucine-rich repeat (NLR) protein with a Toll-like interleukin-1 receptor (TIR) domain, which mediates XopQ recognition in //N. benthamiana// |
| - | * Roq1 is able to recognize XopQ alleles from various // | + | * Roq1 is able to recognize XopQ alleles from various // |
| - | * The coiled-coil NLR protein N requirement gene 1 (NRG) interacts with EDS1 and acts downstream of Roq1 and EDS1 to mediate XopQ/ | + | * The coiled-coil NLR protein N requirement gene 1 (NRG) interacts with EDS1 and acts downstream of Roq1 and EDS1 to mediate XopQ/ |
| - | * Roq1 is also involved in the recognition of RipB, the homolog of XopQ in //Ralstonia solanacearum//: | + | * Roq1 is also involved in the recognition of RipB, the homolog of XopQ in //Ralstonia solanacearum//: |
| - | * Effectors that interact with 14–3–3 proteins may provide plant-pathogenic bacteria with the ability to modulate PTI as well as ETI. Suppression of immune responses induced by a // | + | * Effectors that interact with 14–3–3 proteins may provide plant-pathogenic bacteria with the ability to modulate PTI as well as ETI. Suppression of immune responses induced by a // |
| - | * Roq1 was found to confer immunity to // | + | * Roq1 was found to confer immunity to // |
| - | * Strong resistance to // | + | * Strong resistance to // |
| * // | * // | ||
| - | * A screen for // | + | * A screen for // |
| - | * Expression of XopQ in In //N. benthamiana// | + | * Expression of XopQ in In //N. benthamiana// |
| === Localization === | === Localization === | ||
| Line 56: | Line 58: | ||
| === Enzymatic function === | === Enzymatic function === | ||
| - | XopQ is structurally homologous to an inosine-uridine nucleoside N-ribohydrolase from a protazoan parasite, as shown be [[https:// | + | XopQ is structurally homologous to an inosine-uridine nucleoside N-ribohydrolase from a protazoan parasite, as shown be [[https:// |
| - | Despite such similarities, | + | Despite such similarities, |
| - | In 2014, Yu //et al//. reported the crystal structure of XopQ< | + | In 2014, Yu //et al//. reported the crystal structure of XopQ< |
| === Interaction partners === | === Interaction partners === | ||
| - | Using protein-protein interaction studies in yeast and in planta, XopQ< | + | Using protein-protein interaction studies in yeast and in planta, XopQ< |
| - | Bimolecular fluorescence complementation assays upon transient expression in //N. benthamiana// | + | Bimolecular fluorescence complementation assays upon transient expression in //N. benthamiana// |
| Roq1 (__R__ecognition of X__o__p__Q__), | Roq1 (__R__ecognition of X__o__p__Q__), | ||
| - | XopQ< | + | XopQ< |
| Yeast two-hybrid, bimolecular fluorescence complementation (BiFC) and co-IP assays indicated that XopQ and XopX interact with each other (Deb et al., 2020). | Yeast two-hybrid, bimolecular fluorescence complementation (BiFC) and co-IP assays indicated that XopQ and XopX interact with each other (Deb et al., 2020). | ||
| Line 78: | Line 80: | ||
| === In xanthomonads === | === In xanthomonads === | ||
| - | XopQ is a widely conserved across // | + | XopQ is a widely conserved across // |
| === In other plant pathogens/ | === In other plant pathogens/ | ||
| - | XopQ shares homology with the //Ralstonia solanacearum// | + | XopQ shares homology with the //Ralstonia solanacearum// |
| ===== References ===== | ===== References ===== | ||
| Line 98: | Line 100: | ||
| Deb S, Gupta MK, Patel HK, Sonti RV (2019). // | Deb S, Gupta MK, Patel HK, Sonti RV (2019). // | ||
| - | Dubrow Z, Sunitha S, Kim JG, Aakre CD, Girija AM, Sobol G, Teper D, Chen YC, Ozbaki-Yagan N, Vance H, Sessa G, Mudgett MB (2018). Tomato 14-3-3 proteins are required for //Xv3// disease resistance and interact with a subset of // | + | Dubrow Z, Sunitha S, Kim JG, Aakre CD, Girija AM, Sobol G, Teper D, Chen YC, Ozbaki-Yagan N, Vance H, Sessa G, Mudgett MB (2018). Tomato 14-3-3 proteins are required for //Xv3// disease resistance and interact with a subset of // |
| Furutani A,Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | Furutani A,Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | ||
| Line 135: | Line 137: | ||
| Yu S, Hwang I, Rhee S (2014). The crystal structure of type III effector protein XopQ from // | Yu S, Hwang I, Rhee S (2014). The crystal structure of type III effector protein XopQ from // | ||
| + | |||
| + | ===== Acknowledgements ===== | ||
| + | |||
| + | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||